Trump Says 'No Cash' to mRNA, Investors Say 'Bye Bye'
The Trump administration decided to pull the plug on nearly $500 million meant for mRNA vaccine research, leaving biotech investors nervously clutching their wallets. According to reports, the cut "has made investors more hesitant to back biotechs in this space," which is just a polite way of saying they got cold feet. It's like sitting at a promising restaurant table, then watching the host cancel your reservation right before the appetizer. Science funding or lottery? Either way, no surprise funds went "poof."
Share the Story
(1 of 3)Cutting $500M for vaccine research is like closing a lemonade stand right before summer. Genius moves from the admin that make everyone in biotech wanna sell popcorn instead.
Investors gotta be wondering if funding mRNA research feels like betting on a unicorn or a facade. Spoiler: unicorns need money too.
Trump halts mRNA cash flow, biotech investors duck faster than you running from your 8 AM Zoom. Science just got ghosted.
Source: Statnews | Published: 8/14/2025 | Author: Jonathan Wosen and Allison DeAngelis
More Articles in Politics
MrBeast's Candy Empire Faces Sugar Crash, Now Selling Ethics Instead of Joy
NYC Hotelās Kitchen Uses 2,000 Eggs Weekly to Feed Masses, Not Chickens
Trump Declares Ceasefire Dead But Keeps Talking Anyway, Because Logic
Ann Widdecombe Praises Nigel Farageās 'Decisiveness' Hours Before Passing
House GOP Breaks Record for Most Votes Blocking Their Own Agenda, Still Blames Senate
Trump Jr. Plays Courtroom Legal Analyst While Roommate Reveals Bullet-Dreaming Killer
Trump Turns Iran War Into Truth Socialās First Exploding Meme Marathon
Senate Candidate Plans Dramatic Exit But Forgets To File Paperwork
